Kyverna Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- January 14, 2020
- Vertical
- Cell Therapy
- Funding URL
- View Funding Page
- Funding Amount:
- $25,000,000
Company Info
- Founders
- Dominic Borie
- Company Description
- Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.
- Market
- Autoimmune Diseases
- Location
- Berkeley, California, USA
- Coinvestors
- Gilead Sciences, Vida Ventures, Westlake Village BioPartners